restenosis
美 
英
英漢解釋
例句
Many basic researches are trying to prevent the incidence of restenosis.
許多基礎研究正在嘗試防止其再狹窄的發生。
Drug-eluting stents may reduce the rate of ischemic events in patients with a low restenosis rate.
藥物洗脫支架可降低缺血事件發生頻率，且再狹窄率低。
The recurrence of symptoms several years after an excellent clinical and hemodynamic result may be due to restenosis of the mitral value .
臨床上和血液動力學上取得極好結果，如果過幾年后癥狀復現，可能由二尖瓣重新狹窄所引起。
Coronary restenosis continues to be a major limitation of percutaneous coronary intervention even in the era of intracoronary stenting .
在冠脈支架應用的時代，再狹窄仍然制約著經皮冠脈介入治療。
Puzzle or Hope? Are Endothelial Progenitor Cell Capture Stents the Next Potential Treatment for Restenosis?
內皮祖細胞捕獲支架的困惑與希望？
OBJECTIVE: To compare morphological differences of intracranial target vessel restenosis following various stent implantations.
目的：比較不同材料支架置入后顱內靶血管再狹窄影像形態學差異。
This process, known as restenosis, has been described as "over exuberant" tissue healing and involves the smooth muscle cells.
稱為再狹窄的這個過程一直被描述為組織的超強愈合能力，包括平滑肌細胞。
There is no drug that has been demonstrated universally with definite effect on preventing restenosis so far.
到目前為止，尚沒有一種藥物被臨床普遍證實具有肯定的預防再狹窄形成的作用。
Perspective: CEA is associated with a higher risk of restenosis compared with carotid artery stenting (CAS).
前景：頸動脈內膜剝離術比頸動脈支架有較高的再狹窄風險。
Conclusion: Diabetes may be a powerful predicating factor for restenosis after intracoronary stenting.
結論：糖尿病可作為冠脈內支架植入術后再狹窄的強預測因子。
A striking exception is probucol, which retards atherosclerosis in carotid arteries and restenosis of coronary arteries after angioplasty.
但普羅布考是一個例外，它能夠延緩冠狀動脈血管成形術后再狹窄和頸動脈內粥樣硬化的進展。
Inhibition of intimal hyperplasia or improvement of intima formation and vessel wall remodeling can effectively prevent restenosis.
抑制血管內膜過度增生或改善新生內膜形成以及血管重塑過程均可有效防止再狹窄。
Objective: Setting up the experimental animal model of restenosis.
前言：目的：建立再狹窄動物實驗模型。
Conclusion It showed that intravascular low power red laser illumination could prevent arterial restenosis after balloon injury.
結論低能量紅激光局部照射可以顯著減少血管成形術后再狹窄的形成。
Objective To observe the effects of pioglitazone on stent restenosis in coronary heart disease patients with impaired glucose tolerance.
目的觀察吡格列酮對冠心病合并糖耐量異常患者冠脈支架內再狹窄的影響。
It causes little injuries. OPCAB would be the first choice for treatment of restenosis of multivesselswith diffuse lesions.
對于多支彌漫性支架再狹窄病變，OPCAB可考慮作為首選。
Drug therapy is a most direct and convenient method for prevention of restenosis after percutaneous coronary intervention.
藥物治療是預防冠狀動脈內介入治療后再狹窄的最直接、最簡便的方法。
The restenosis of vein grafts which result from neointima and atherosclerosis has became an urgent problem to be resolved.
新內膜形成和動脈粥樣硬化導致的靜脈橋再狹窄已成為一個亟待解決的問題。
Coronary artery stents have been developed to prevent acute coronary closure and reduce restenosis after coronary angioplasty.
血管支架的置放可以避免冠狀動脈急性阻塞及減少血管再狹窄。
The trial studied 396 patients whose bare metal stents had become clogged with scar tissue, a common complication called restenosis.
實驗研究了396位使用外露金屬支架的患者，由于傷口產生疤痕組織而經常出現術后再閉。
To evaluate the clinical effect of cutting ballon used to managepoststenting restenosis in lower limb arteries.
目的觀察切割球囊處理下肢動脈支架術后再狹窄的臨床效果，評價其應用價值。
Objective To evaluate the curative effect and coronary artery restenosis after PTCA by stress myocardial perfusion imaging(MPI).
目的應用負荷心肌灌注顯像方法評價冠心病患者經PTCA術后的療效及冠狀動脈再狹窄情況。
Drug-eluting stents decrease the incidence of restenosis, but concerns have been raised about the risk for late thrombosis.
藥物支架減少再狹窄的發生，但卻引起晚發血栓的增加。
Recently, special drugs are carried by stents(drug-eluting stents) to further reduce in-stent restenosis rate after stenting procedure.
支架植入血管后可能發生的血管內再狹窄，藥物洗脫支架的臨床應用在一定程度上降低了再狹窄的發生。
Objective To assess the safety and therapeutical efficiency of dual-wire balloon using in treating coronary artery in-stent restenosis.
目的評價雙導絲球囊在冠脈支架內再狹窄治療中的的安全性和療效。
The stent has smaller mesh, can effectively lower the postoperative restenosis rate, and improves the medical treatment effect.
本發明提供的支架網孔比較小，能夠有效地降低術后再狹窄率，提高醫療效果。
We reviewed the roles of insulin in the pathogenesis of atherosclerosis and restenosis, and discussed the possible mechanisms.
現對胰島素在動脈粥樣硬化和再狹窄發病過程中的作用進行綜述，并總結其可能的作用機制。
Vascular Brachytherapy is essentially the sole available treatment modality for in-stent restenosis.
血管腔內放療基本上是唯一的治療方法提供的支架內再狹窄。
The current state of gene therapy for vein graft restenosis and the new technologies that may be adopted in the future are reviewed.
現對基因治療靜脈橋再狹窄現狀及將來可能應用技術作一綜述。
The artery in which the stent is placed, however, can become blocked again during a process called restenosis.
但是擴張后的血管可能由于管腔“再狹窄”作用而再次堵塞。
But restenosis after carotid endarterectomy has become a key factor influencing the efficacy of operation.
但內膜切除術后發生的再狹窄現已成為影響手術療效的關鍵因素。
AIM: To explore the role of intimal hyperplasia and vascular remodeling in the formation of vascular restenosis.
目的：探討在血管再狹窄形成過程中內膜增生及血管重塑的作用。
clinical application shows that cobalt alloy might result in restenosis after insertion.
臨床應表明鈷合金支架植入后存在再狹窄的危險等問題。
RESULTS: Restenosis is the most obvious problem after percutaneous transluminal coronary angioplasty and stenting.
結果：經皮冠狀動脈腔內成形和支架置入后的最突出問題是血管再狹窄。
The incidence of complications following stenting is 11. 6%, including acute or subacute thrombogenesis, restenosis, or stent dislocation.
血管內支架置入后并發癥的發生率為11.6%，主要并發癥有急性或亞急性血栓形成，再狹窄，支架脫落等。
Background It will be faced that after Percutaneous coronary intervention(PCI) in-stent restenosis may happen.
背景預防支架內再狹窄是經皮冠狀動脈介入性治療（PCI）術后必須面對的問題。
Pathologic evidence of edge restenosis was seen in three radioactive stent groups.
部分放射性支架組動物可見邊緣狹窄的影像學與病理學依據。
Moreover, the restenosis following stenting is related to stent type and medicine supportive treatment.
血管支架置入后發生再狹窄的影響因素還與支架的種類和相關藥物支持治療相關。
Inflammation plays a major role in determining in-stent restenosis via neointimal proliferation.
炎癥反應通過刺激內膜增生在支架置入術后再狹窄的過程中發揮重要作用。
This article reviews the pathology and prevention for in-stent restenosis.
現就支架再狹窄的病理及其防治作一綜述。
